Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% change compared to its last close.

For fiscal 2025, management expects sales to range between $147 billion and $151 billion, while adjusted EPS is forecast to ...

Big swings up and down have become typical for Super Micro, which is caught between the hype of artificial intelligence and concerns about the firm’s finances.

In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

For the current quarter, Pfizer is expected to post earnings of $0.48 per share, indicating a change of +380% from the year-ago quarter. The Zacks Consensus Estimate has changed -3.7% over the last 30 ...

If generating more passive income is one of your New Year's resolutions, you have plenty of options for achieving the goal.

Jensen Huang unveiled the chip designer’s next-generation gaming graphics cards at the CES tech trade show in Las Vegas on Monday.

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.59 which represents a decrease of $-0.02 or -0.08% from the prior close of $26.61. The stock opened at $26.7 and touched a low of ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Pfizer Inc. (NYSE:PFE – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings ...

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) were down 0.2% during trading on Friday . The company traded as low as $26 ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...